About this trial
To evaluate the utility of DCR-derived parameters for identifying dynamic functional imaging phenotypes, assessing disease severity, and predicting the risk of disease progression in COPD.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 30-85 years.
Male or female.
Patients who underwent pulmonary function testing and dynamic chest radiography at the hospital.
Disqualifiers
Incomplete medical records.
Considered unsuitable for inclusion in the study at the investigator's discretion.
Trial population
Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by chronic respiratory symptoms, including dyspnea, cough, and sputum production. These symptoms result from airway abnormalities, such as bronchitis or bronchiolitis, and/or alveolar abnormalities, such as emphysema, that cause persistent and often progressive airflow obstruction.
Trial design
Cohort
Retrospective
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Exacerbation/respiratory history and event
Measurement of disease control and burden
FEV1 %
Measurement of lung function
FEV1 /FVC
Measurement of lung function
Emphysema
Measurement of chest CT
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Nanfang Hospital, Southern Medical University
Lead sponsor
The First Affiliated Hospital of Guangzhou Medical University
Collaborator
Qingyuan People's Hospital
Collaborator